My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Tickers GS LLY MRK NVDA
Tags GS MRK NVDA
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Tickers BMY CI CNC CVS
Tags Top Stories WBA MRK
From Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Tickers AMGN AZN BMY EXEL
Tags GILD MRK General
From Benzinga
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
Tickers AZN NEWS NVS PTCT
Tags News PTCT NVS
From Benzinga
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Tickers JANX NEWS NVS
Tags News Expert Ideas NVS
From Benzinga
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
Tickers NEWS NVS PTCT
Tags Briefs Biotech Large Cap
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
Tickers NVS V
Tags NVS Recent Press Releases Market News
From Motley Fool
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Tickers NEWS NVS
Tags Stories That Matter Top Stories General
From Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Tickers ARKG NEWS NVS SDGR
Tags Equities Stories That Matter General
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags General Stories That Matter BMY
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Benzinga Briefs Biotech
From Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
Tickers NVS
Tags Recent Press Releases NVS Market News
From Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
Tickers NEWS NVS
Tags Top Stories Stories That Matter General
From Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Tickers GLUE NEWS NVS
Tags Briefs Benzinga Movers
From Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
Tickers GILD MRK NVS
Tags Recent Press Releases NVS Market News
From Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Tickers CTLT NEWS NVO NVS
Tags Market News CTLT NVS
From Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags Equities Stories That Matter General
From Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Tickers NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags ALPMF Price Target Analyst Ratings
From Benzinga
Looking Into Novartis's Recent Short Interest
Tickers NVS
Tags Short Sellers BZI/SHORTHIST Benzinga
From Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
Tickers ABBV NVS
Tags ABBV NVS Recent Press Releases
From Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
Tickers NEWS NVS OKUR
Tags Stories That Matter Top Stories Analyst Ratings
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags SNY Briefs Biotech
From Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
Tickers INCY NEWS NVS
Tags Benzinga INCY Large Cap
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags Health Care Briefs SNY
From Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Tickers ACET ANIP NEWS NVS
Tags Trading Ideas RLAY ANIP
From Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers APP ASO ATOS CAC
Tags Markets Price Target Analyst Ratings
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags Market News PFE NVS
From Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
Tickers NEWS NVO NVS
Tags Movers Trading Ideas Health Care
From Benzinga
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Tickers AI CE CHPT CNM
Tags CHPT Pre/Market Outlook Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.